Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Bozhenko Vk"'
Autor:
I. I. Burdina, E. A. Kudinova, Bozhenko Vk, S. P. Prokopenko, N. I. Rozhkova, S. B. Zapirova, O. E. Yakobs, P. G. Labazanova, S. Yu. Mikushin, M. L. Mazo
Publikováno v:
Medical alphabet. :21-29
The review presents the latest data on the development of a new direction of interdisciplinary integration of radiation and molecular biological technologies ‘omi с s', including high technologies in the field of genomics, transcriptomics, proteom
Publikováno v:
CLINICAL AND EXPERIMENTAL MORPHOLOGY. 9:33-39
Autor:
Valeriy Krylov, Andrey Kaprin, Dmitriy Fomin, Bozhenko Vk, O. Avilov, Feliks Sevryukov, Vladimir Solodkiy, Stefan Ivanov, Yekaterina Dzhikiya, Timur Izmaylov, Yu. Blanter
Publikováno v:
Problems in oncology. 65:83-87
Recently, there has been an increase in the incidence and detectability of patients with differentiated thyroid cancer. At the same time in a number of patients in the combined treatment, initially low susceptibility of regional metastases to radioio
Publikováno v:
Bulletin of Russian State Medical University. :65-70
Research into the effects of radiation delivered at ultrahigh dose rates > 1 × 107 Gy/min to biological objects is a new promising area of radiobiology. The unique characteristics of the high-current nanosecond electron accelerator Mir-M enable its
Autor:
A. G. Tsov’yanov, Bozhenko Vk, T. I. Gimadova, G. M. Oleinik, A. N. Gritsuk, V. P. Smirnov, E. V. Grabovski, A. V. Ivanov, A. M. Shishkin, E. V. Khmelevskii
Publikováno v:
Plasma Physics Reports. 44:1169-1174
Radiological methods of treatment of malignant tumors are widespread in medical practice. In addition to the type of radiation and dose and fractionation of the radiation regime, the dose rate is one of the factors that affects the effectiveness of t
Autor:
Yana Serdyuk, Tatiana V. Radaeva, Irina V. Lyadova, Alexander A Nikolaev, George A. Kosmiadi, Lubov A. Gorelova, Irina Yu. Nikitina, Alexander V. Panteleev, Tatiana A. Nenasheva, Bozhenko Vk, Yana Yu. Kiseleva
Publikováno v:
The Journal of Immunology. 200:2090-2103
Th1 lymphocytes are considered the main mediators of protection against tuberculosis (TB); however, their phenotypic characteristics and relationship with Th17 and Th1Th17 populations during TB are poorly understood. We have analyzed Th1, Th17, and T
Autor:
G.M. Oleynik, E.V. Khmelevsky, V. P. Smirnov, E.V. Grabovsky, A. V. Ivanov, Bozhenko Vk, A. M. Shishkin, T. M. Kulinich, E.G. Krastelev
Publikováno v:
Scopus-Elsevier
Autor:
Bozhenko Vk, N. V. Kharchenko, E. A. Kudinova, I.D. Trotsenko, A. V. Oorzhak, Rozhkova Ni, E. F. Vaskevich
Publikováno v:
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry. 10:75-80
Currently, no molecular biological markers do exist for early diagnosis of breast cancer. One of the possible candidates for the marker of early breast cancer is mammaglobin (MGB1) or SCGB2A2 (secretoglobin, family 2A, member 2), characterized by the
Publikováno v:
Bulletin of experimental biology and medicine. 166(6)
We studied the effect of low and high-dose rate photon radiation on activation of cell death by apoptosis and necrosis in malignant cell lines of lymphocytic origin Raji and Jurkat (human B and T-cell lymphomas) and normal human lymphocytes from heal
Autor:
Yaroslav Kholodov, N. D. Shuvalov, Bozhenko Vk, Andrey Alekseenko, Tatiana Kulinich, Andrey Kazennov
Publikováno v:
Computational Molecular Bioscience. :53-57
The goal of this work is the development of novel peptides with high efficacy of inhibiting activity of CDK6/CyclinD complex. The peptides were derived from primary sequence of P16 protein and its homologues. The interactions between CDK6 and P16/INK